Tokyo Metropolitan University scientists have found a natural sulfur swap in archaeal RNA, revealing a new backbone modification and the enzymes that help life endure extreme heat.
Europe’s biotech labs are buzzing with breakthroughs, but most discoveries never reach the market. Billions in ERC funding can’t close the gap as money and support dry up before ideas become real products.
A wave of blockbuster deals from Samsung Biologics, SK Biopharm, and Hanmi Pharmaceutical has pushed South Korea to the front of Asia-Pacific biopharma. Big acquisitions and licensing moves are changing the region’s global standing.
In the first half of 2026, the FDA cleared 22 new cancer treatments. AstraZeneca topped the sponsor list, and pembrolizumab became the backbone of new drug combinations. The focus is shifting to pairing proven drugs.
GenoMethods explains biotechnology from method to medicine to market, connecting scientific evidence, clinical development, companies and the technologies shaping future health.
